User:Mr. Ibrahem/Bezlotoxumab

Bezlotoxumab, sold under the brand name Zinplava, is a medication used in Clostridium difficile infections to prevent recurrence. It is used together with antibiotics. It is given by injection into a vein.

Common side effects include nausea, diarrhea, fever, and headache. Other side effects may include heart failure. Safety in pregnancy is unclear. It is a monoclonal antibody that binds to Clostridium difficile toxin B.

Bezlotoxumab was approved for medical use in the United States in 2016 and Europe in 2017. In the United Kingdom a 1,000 mg vial costs the NHS about £2,500 as of 2021. This amount in the United States costs about 4,000 USD.